Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04140344 · ClinicalTrials.gov registry record · NA

The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

A NA study of Lumbar Spine Degeneration and Lumbar Spondylosis, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT04140344 is a NA study of Lumbar Spine Degeneration and Lumbar Spondylosis that is actively recruiting participants, run by Duke University. The registered enrollment target is 224 participants, below the 612-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04140344, a NA study of Lumbar Spine Degeneration and Lumbar Spondylosis, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The purpose of this single-blind, randomized, controlled study is to assess the efficacy of "informative text messages" vs "traditional handouts" provided to lumbar spine surgery patients post-operatively.

Interventions

  • OTHER Text Message Group

Study Locations (1)

North Carolina

  • Duke Neurosurgery and Duke Orthopedics - Durham

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2023-09-07
Est. Completion 2027-10
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04140344

The ClinicalTrials.gov registry entry for NCT04140344 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 612-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (63% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lumbar Spine Degeneration appearing as the primary indexed condition, and to 1 intervention - of which Text Message Group is the first listed.

NCT04140344 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04140344 about?

NCT04140344 is a clinical study titled "The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions". The purpose of this single-blind, randomized, controlled study is to assess the efficacy of "informative text messages" vs "traditional handouts" provided to lumbar spine surgery patients post-operatively.

What is the current status of trial NCT04140344?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2023-09-07. Estimated completion is 2027-10.

What conditions does trial NCT04140344 study?

This clinical trial studies the following conditions: Lumbar Spine Degeneration, Lumbar Spondylosis, Lumbar Spine Instability.

What interventions are being tested in trial NCT04140344?

The interventions under investigation include: Text Message Group (OTHER).

Who is sponsoring clinical trial NCT04140344?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04140344 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lumbar Spine Degeneration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.